Today: 27 October 2025
11 February 2021
2 mins read

WHO backs AstraZeneca vaccine use amid concerns

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to be higher when the interval between doses was within the four to 12 weeks range…reports Asian Lite News

https://www.youtube.com/watch?v=uDMHC59PCnQ

The World Health Organization (WHO) has decided that potential benefits of the Oxford-AstraZeneca Covid-19 vaccine outweigh known and potential risks, amid concerns over its efficacy against the virus variant found in South Africa.

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to be higher when the interval between doses was within the four to 12 weeks range, reports Xinhua news agency.

It also added that although preliminary analyses based on a small sample size in South Africa indicate a marked reduction in vaccine effectiveness against mild and moderate disease, it did not allow a specific assessment of vaccine efficacy against severe Covid-19.

As indirect evidence is compatible with protection against severe Covid-19, the situation remains to be demonstrated in ongoing clinical trials and post-implementation evaluations.

In view of this, WHO currently recommends the use of the AstraZeneca vaccine even if the variants are present in a country.

Countries should conduct a benefit-risk assessment according to the local epidemiological situation, including the extent of circulating virus variants.

“We have made a recommendation that even if there is a reduction in the possibility of this vaccine having a full impact in its protection capacity, especially against severe disease, there is no reason not to recommend its use even in countries that have circulation of the variant,” said SAGE chair Alejandro Cravioto at a briefing on Wednesday.

Meanwhile, SAGE cautioned that as there are currently no efficacy or safety data for children or adolescents below the age of 18 years, vaccination of individuals below 18 years of age is not recommended until such data are available.

South Africa said recently that the rollout of the AstraZeneca vaccine in the country would be temporarily put on hold until more “clinically efficacy information” of the vaccine against new Covid-19 variant becomes available.

The decision came after a study showed that the AstraZeneca vaccine was less effective against the new variant found in South Africa.

Also read:2.3 mn voters register for upcoming Palestinian polls

Previous Story

2.3 mn voters register for upcoming Palestinian polls

Next Story

IS threats spike again: UN

Latest from -Top News

Gazans Struggle to Revive Life

Today, Gaza’s markets seem to awaken from beneath the ruins. Partially destroyed shops opened their doors amid streets littered with debris, while merchants attempt to arrange what remains of their goods on

GAZA AID: MSF raps Israel

Doctors Without Borders (MSF) says Israel Continues to Use Aid as a Weapon of War Against Gaza Strip…reports Asian Lite News Doctors Without Borders (MSF) said that despite the ceasefire agreement, Israel

Qatar Emir Meets Trump

HH the Amir welcomed HE the US President and his accompanying delegation, expressing his pleasure at meeting the President during his stopover in Qatar…reports Asian Lite News HH the Amir Sheikh Tamim

Abu Dhabi leads future of food innovation

Global Food Week 2025 cements Abu Dhabi’s leadership in food innovation, uniting 75 countries to showcase sustainable agriculture, cutting-edge technologies, and women-led enterprises driving future food security….reports Asian Lite News Global Food

UAE reshapes AI council

The newly reconstituted Council will be chaired by His Highness Sheikh Tahnoon bin Zayed Al Nahyan, with His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan serving as Vice-Chairman….reports Asian Lite
Go toTop